← All indications
Hyperkalemia
Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)
Drugs by status
Approved for this indication (4)
Phase 4 trials (10)
Phase 3 trials (4)
Phase 1 trials (2)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (25)
- ZS Pharma, Inc.
- AstraZeneca
- Baylor University
- Case Western Reserve University
- Cornell University
- Duke University
- Hospital Avicenne
- The Rogosin Institute
- University of California, Irvine
- University of Copenhagen
- University of Angers
- University of Montreal
- University of Nantes
- University of Nice Sophia Antipolis
- University of Paris
- University of Poitiers
- CHU Louis Mourier
- University of Grenoble
- University of Lorraine
- Assistance Publique - Hôpitaux de Paris
- University Hospital, Tours
- University Clermont Auvergne
- Agen Hospital
- Comprehensive Research Associates
- Steno Diabetes Center Copenhagen
Organization Involved with Phase 3 Indications (3)
Organization Involved with Phase 2 Indications (4)
Organization Involved with Other Experimental Indications (6)